Vascular Inflammation: A Novel Access Route for Nanomedicine

Area of Science:

• Cardiovascular Medicine
• Inflammation Research
• Vascular Biology

Background:

• Cardiovascular disease (CVD) remains a leading cause of death in the US, despite advances in treatment.
• Chronic systemic inflammation, linked to conditions like obesity and cancer, significantly contributes to CVD development.
• Inflammation promotes leukocyte adhesion and infiltration in the endothelium, initiating and worsening CVD.

Purpose of the Study:

• To review the role of inflammation in cardiovascular disease (CVD) pathophysiology.
• To explore novel therapeutic strategies targeting inflamed vasculature for CVD treatment.
• To discuss the potential of endogenous anti-inflammatory molecules and targeted delivery systems.

Main Methods:

• Literature review of current research on inflammation and CVD.
• Analysis of new-generation therapies and targeted approaches for CVD.
• Discussion of conventional and biomimetic strategies for targeting inflamed endothelium.

Main Results:

• Systemic inflammation is a key driver of endothelial dysfunction and CVD progression.
• Endogenous anti-inflammatory molecules offer potential cardiovascular benefits.
• Targeted therapies can exploit endothelial differences to selectively deliver treatments.

Conclusions:

• Understanding inflammation's role in CVD is crucial for developing effective treatments.
• Targeting inflamed vasculature presents a promising therapeutic avenue for reducing CVD morbidity and mortality.
• Future research should focus on leveraging anti-inflammatory and targeted approaches for CVD management.